School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
Contemp Clin Trials. 2012 Sep;33(5):853-9. doi: 10.1016/j.cct.2012.04.003. Epub 2012 Apr 20.
In order to address the limitations of the standard pragmatic RCT design, the innovative 'cohort multiple RCT' design was developed. The design was first piloted by addressing a clinical question " What is the clinical and cost effectiveness of treatment by a homeopath for women with menopausal hot flushes?".
A cohort with the condition of interest (hot flushes) was recruited through an observational study of women's midlife health and consented to provide observational data and have their data used comparatively. The 'Hot Flush' Cohort were then screened in order to identify patients eligible for a trial of the offer of treatment by a homeopath (Eligible Trial Group). A proportion of the Eligible Trial Group was then randomly selected to the Offer Group and offered treatment. A "patient centred" approach to information and consent was adopted. Patients were not (i) told about treatments that they would not be offered, and trial intervention information was only given to the Offer Group after random selection. Patients were not (ii) given prior information that their treatment would be decided by chance.
The 'cohort multiple RCT' design was acceptable to the NHS Research Ethics Committee. The majority of patients completed multiple questionnaires. Acceptance of the offer was high (17/24).
This pilot identified the feasibility of an innovative design in practice. Further research is required to test the concept of undertaking multiple trials within a cohort of patients and to assess the acceptability of the "patient centred" approach to information and consent.
为了解决标准实用随机对照试验设计的局限性,创新性地开发了“队列多次 RCT 设计”。该设计首先通过解决一个临床问题“对于绝经期潮热的女性,顺势疗法的治疗的临床和成本效益如何?”进行了试点。
通过对女性中年健康的观察性研究招募了有兴趣的队列(潮热),并同意提供观察数据并比较其数据。然后对“潮热”队列进行筛选,以确定有资格接受顺势疗法治疗的患者(合格试验组)。然后从合格试验组中随机选择一部分进入提供治疗的提供组。采用“以患者为中心”的信息和同意方法。未向患者(i)告知他们不会接受的治疗方法,并且仅在随机选择后才向提供组提供试验干预信息。患者(ii)没有事先被告知他们的治疗将由机会决定。
“队列多次 RCT”设计得到了 NHS 研究伦理委员会的认可。大多数患者完成了多项问卷调查。接受率很高(17/24)。
该试点确定了在实践中实施创新设计的可行性。需要进一步研究来检验在患者队列中进行多次试验的概念,并评估“以患者为中心”的信息和同意方法的可接受性。